tradingkey.logo

Inspire Medical Systems Inc

INSP
66.330USD
+0.630+0.96%
收盤 02/09, 16:00美東報價延遲15分鐘
1.34B總市值
44.24本益比TTM

Inspire Medical Systems Inc

66.330
+0.630+0.96%

關於 Inspire Medical Systems Inc 公司

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.

Inspire Medical Systems Inc簡介

公司代碼INSP
公司名稱Inspire Medical Systems Inc
上市日期May 03, 2018
CEOHerbert (Timothy P)
員工數量1246
證券類型Ordinary Share
年結日May 03
公司地址5500 Wayzata Blvd Ste 1600
城市GOLDEN VALLEY
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編55416-1237
電話17639575037
網址https://www.inspiresleep.com/
公司代碼INSP
上市日期May 03, 2018
CEOHerbert (Timothy P)

Inspire Medical Systems Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
77.13K
-294921.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
23.42K
+181.00%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
6.36K
-4865.00%
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
4.57K
+200.00%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
4.54K
+4541.00%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
3.37K
-4.00%
Mr. Randall A. (Randy) Ban
Mr. Randall A. (Randy) Ban
Executive Vice President - Patient Access and Therapy Development
Executive Vice President - Patient Access and Therapy Development
--
--
Mr. Richard J. (Rick) Buchholz
Mr. Richard J. (Rick) Buchholz
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Dana G. Mead, Jr.
Mr. Dana G. Mead, Jr.
Independent Director
Independent Director
--
--
Mr. Shawn T. Mccormick
Mr. Shawn T. Mccormick
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
77.13K
-294921.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
23.42K
+181.00%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
6.36K
-4865.00%
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
4.57K
+200.00%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
4.54K
+4541.00%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
3.37K
-4.00%

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
214.39M
95.50%
All other countries
10.11M
4.50%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 2月2日 週一
更新時間: 2月2日 週一
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
10.97%
The Vanguard Group, Inc.
10.14%
Wellington Management Company, LLP
6.03%
Citadel Advisors LLC
5.90%
Deerfield Management Company, L.P.
5.08%
其他
61.88%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
10.97%
The Vanguard Group, Inc.
10.14%
Wellington Management Company, LLP
6.03%
Citadel Advisors LLC
5.90%
Deerfield Management Company, L.P.
5.08%
其他
61.88%
股東類型
持股股東
佔比
Investment Advisor
45.18%
Investment Advisor/Hedge Fund
32.82%
Hedge Fund
27.41%
Research Firm
7.27%
Pension Fund
2.17%
Sovereign Wealth Fund
0.96%
Individual Investor
0.87%
Bank and Trust
0.59%
Venture Capital
0.42%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
829
33.78M
116.26%
-6.67M
2025Q3
828
32.29M
111.12%
-7.29M
2025Q2
883
35.48M
119.97%
-4.91M
2025Q1
912
35.71M
121.08%
-5.66M
2024Q4
874
35.22M
118.69%
-4.72M
2024Q3
852
35.48M
118.45%
-2.86M
2024Q2
825
33.60M
112.73%
-2.85M
2024Q1
801
33.20M
111.87%
-2.01M
2023Q4
786
32.35M
109.45%
+751.92K
2023Q3
753
29.93M
101.80%
-635.63K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
3.19M
10.97%
-303.16K
-8.69%
Sep 30, 2025
The Vanguard Group, Inc.
2.99M
10.3%
-203.50K
-6.37%
Sep 30, 2025
Citadel Advisors LLC
1.71M
5.9%
-35.37K
-2.02%
Oct 06, 2025
Deerfield Management Company, L.P.
1.48M
5.08%
+428.61K
+40.91%
Nov 06, 2025
William Blair Investment Management, LLC
1.30M
4.47%
+528.40K
+68.70%
Sep 30, 2025
State Street Investment Management (US)
979.31K
3.37%
-51.59K
-5.00%
Sep 30, 2025
Braidwell LP
883.75K
3.04%
+361.34K
+69.17%
Sep 30, 2025
Soleus Capital Management, L.P.
728.19K
2.51%
+619.19K
+568.06%
Sep 30, 2025
Janus Henderson Investors
667.08K
2.3%
+26.16K
+4.08%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Global X HealthTech ETF
2.68%
State Street SPDR S&P Health Care Equipment ETF
1.63%
Invesco S&P SmallCap Health Care ETF
1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
0.53%
iShares S&P Small-Cap 600 Growth ETF
0.43%
VictoryShares Small Cap Free Cash Flow ETF
0.36%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.34%
State Street SPDR S&P 600 Small Cap Growth ETF
0.27%
WisdomTree US SmallCap Quality Growth Fund
0.26%
查看更多
Global X HealthTech ETF
佔比2.68%
State Street SPDR S&P Health Care Equipment ETF
佔比1.63%
Invesco S&P SmallCap Health Care ETF
佔比1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
佔比0.53%
iShares S&P Small-Cap 600 Growth ETF
佔比0.43%
VictoryShares Small Cap Free Cash Flow ETF
佔比0.36%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
佔比0.34%
State Street SPDR S&P 600 Small Cap Growth ETF
佔比0.27%
WisdomTree US SmallCap Quality Growth Fund
佔比0.26%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI